Midlife Skin, Hair & Intimate Health: Hormones Behind the Changes
Episode Summary: Midlife Skin, Hair & Intimate Health
In this episode of the Hormona Vida Functional Medicine Podcast, we take an integrative look at how hormonal changes in midlife and menopause affect your skin, hair, and intimate health. We explore why estrogen acts like a conductor for skin health, how the “collagen cliff” and chronic dryness develop, and why weight training becomes non-negotiable when muscle and connective tissue begin to change.
We also break down the complex drivers of female hair loss, including the role of DHT, thyroid health, iron deficiency, and different types of alopecia. Finally, we discuss genitourinary syndrome of menopause (GSM): what it is, how it affects the vulva, vagina, urethra, and bladder, and what evidence-based options exist from local estrogen and hyaluronic acid to pelvic floor strengthening and technologies like the Emsella chair.
Key Takeaways
- Estrogen and DHEA act as key regulators for skin health, influencing collagen, elastin, and natural oils. Their decline contributes to thinning, dryness, and loss of elasticity.
- Women can lose a significant amount of collagen in the first years after menopause the “collagen cliff” making daily sun protection, barrier support, and sometimes BHRT especially important.
- Midlife hair loss has multiple drivers, including estrogen decline, DHT, stress, thyroid dysfunction, and nutritional deficiencies. Early diagnosis (for example, through trichoscopy) is essential.
- Genitourinary syndrome of menopause (GSM) is a chronic, estrogen-dependent condition affecting the vulva, vagina, and urinary tract, but it is highly treatable with local hormones and non-hormonal options.
- A comprehensive approach BHRT when appropriate, strength training, sleep, stress management, pelvic floor support, and targeted topicals helps women manage visible and invisible midlife changes with greater confidence.
Frequently Asked Questions
Why does my skin change so much during midlife and menopause?
Estrogen helps your skin produce collagen, elastin, and natural oils. As estrogen and DHEA decline in midlife, collagen production slows, the epidermis can thin, and the skin barrier becomes drier and more reactive. This leads to more visible fine lines, crepiness, and chronic dryness.
What causes hair thinning and hair loss in midlife women?
Estrogen supports a long growth phase for hair. When estrogen falls, that phase shortens. At the same time, normal testosterone can convert to DHT, which miniaturizes follicles over time. Stress, low iron or ferritin, thyroid dysfunction, and some types of scarring alopecia can also contribute, so early evaluation is important.
What is genitourinary syndrome of menopause (GSM)?
GSM is a chronic set of symptoms affecting the vulva, vagina, urethra, and bladder due to low estrogen. Tissues become thinner and less elastic, pH becomes more alkaline, and infections and urinary symptoms can increase. Common complaints include dryness, burning, pain with sex, urgency, frequency, and recurrent UTIs.
What treatments can help with GSM and midlife skin/hair changes?
Options include local vaginal estrogen or estriol, intravaginal hyaluronic acid, lubricants, barrier repair and antioxidant skincare, strength training, stress and sleep support, and hair therapies like topical or oral minoxidil. Some women may also benefit from BHRT and pelvic floor technologies such as the Emsella chair. All decisions should be made with a qualified clinician who knows your health history.
Transcript
Welcome back to the deep dive. If you're navigating midlife changes, you probably know that the shifts happening internally often show up pretty clearly on the surface.
Oh, absolutely. We see it all the time. We're talking about dry skin, maybe some unexpected spots, or that really unsettling feeling of your hair thinning. It's visible and, frankly, it can be really stressful.
That feeling of being a victim of age is exactly what we aim to conquer with knowledge. Our mission is really about empowerment, right? When you understand the underlying hormonal drivers, you can move from just reacting to things to proactively managing your own health and vitality.
Absolutely. And today, that's what we're doing. We're taking an integrative approach. We are diving deep into those changes you see in the mirror your skin, your hair and an area that is so vital but often goes undiscussed: intimate health.
Yes, exactly. We're looking at why combining lifestyle, targeted care, and hormone support is so essential. We've broken this down into three core areas. First, we'll talk about how estrogen acts as the conductor for your skin's health. Second, we'll unpack the really complex drivers behind hair loss and that thinning we mentioned. And third, we'll explore and explain something called genitourinary syndrome of menopause, or GSM.
Okay, let's start with the skin. Our largest organ. Research really positions estrogen as the director of the orchestra for skin health. It's a perfect analogy. When estrogen and DHEA which can start to decline around age 40 drop, the consequences for the skin are profound.
So what is estrogen actually doing in the skin? It's the signal. It's the hormone that tells your skin cells, specifically the fibroblasts, to produce collagen and elastin the building blocks. And it also influences the sebaceous glands, which produce oil. So when that signal weakens, production slows way down.
And it's important to remember this is a whole-body thing, not just the skin. You mentioned DHEA, and we know this decline is systemic. For instance, muscle mass loss, or sarcopenia, can start around 40, at a rate of about 1–2% per year. Whether we look inside the body at connective tissue or at the surface, we're seeing the same hormonal drivers at work.
Which is why we're always talking about heavy weight training. It becomes non-negotiable. You're fighting a systemic process. You really are.
Okay, back to the skin. The numbers around collagen loss are honestly shocking. Some evidence suggests women can lose up to 30% of their collagen in the first five years after menopause. That's the “collagen cliff.” It's a staggering figure.
And what's really important to grasp is that this rapid loss is more linked to estrogen deficiency than it is to just chronological age. It's the hormonal shift, not just the birthday. After that initial cliff, the loss slows to about 2% a year, but by then a lot of the structure has already changed. The epidermis the outer layer can thin by almost half.
Wow. And you can actually see this loss of elasticity. I've heard you talk about the pinch test.
Yes, it's a simple check. Just pinch the skin on the back of your hand. If it takes more than a second or two to flatten back out, that's a real-time sign of lost elasticity, or elastosis.
And that's compounded by dryness, right? A compromised barrier is a huge factor. Over half of women over 65 report experiencing xerosis cutis that's just the clinical term for chronic dry skin. It's largely from that reduction in natural oils. Your skin is supposed to be your armor against bacteria and pollution. When it's dry, that armor is weakened. You suddenly become more susceptible to things like contact dermatitis. Your skin reacts to things it never did before.
And what about outside factors like the sun? A huge one. Oxidative stress from sun exposure or from smoking activates enzymes we sometimes call the matrix metalloproteinases. It's a mouthful. Think of them as tiny Pac-Man enzymes. They literally chew up your existing collagen. So you have lower production and increased destruction. That's a double whammy.
It really is. Let's talk about spots and pigment. Melasma or hyperpigmentation we know that's hormone-linked.
It is. Estrogen influences the melanocytes, the cells that produce pigment. But not all spots are the same.
You mean like sun spots? Exactly. Solar lentigines those classic sun spots that reflect accumulated damage. They're basically the bill for the sun you got 20 or 30 years ago. That's UV radiation, not your current hormone levels, although they might look more obvious as the skin thins.
So, okay, what can we do? What are the actionable takeaways here?
It starts with the basics: daily, consistent sunscreen on the face, neck, and hands arms too if they're exposed. It's absolutely non-negotiable for prevention. Topicals matter as well. Topical antioxidants like vitamin C and E are key defenses and support cell turnover. A clinician might recommend a retinol or glycolic acid, maybe on alternate nights, and of course hyaluronic acid for surface hydration.
What about the body? It always seems to get neglected and feels so much drier.
It does. Ingredients like urea around a 10% concentration can help bind water to the skin. In the winter especially, sealing that in with something occlusive, like a petrolatum-based ointment or Aquaphor, is essential. It physically locks in the moisture.
Now, in the context of hormonal support, what does the evidence suggest BHRT might do for skin?
Some studies indicate that bioidentical hormone replacement even applied locally may improve skin thickness, elasticity, and measurable collagen production. We often see these positive effects after about three to six months.
I've heard about more advanced options, like SERMs selective estrogen receptor modulators. It sounds very technical.
It does, but the concept is pretty straightforward. Think of estrogen as a key. It fits into different keyholes, or receptors, in your body. You have alpha receptors, mostly in the uterus and breast, and you have beta receptors, found more in skin, bone, and mucosal linings. Different keyholes, different effects.
SERMs are like smart keys. They're designed to activate the beta receptors the ones in the skin while hopefully avoiding the alpha receptors. It's about getting the benefits without stimulating other tissues. It's highly nuanced, of course. And for more advanced staging there are in-clinic options like lasers. Biostimulation or fractional CO₂ laser treatments can improve texture and firmness, but a key thing to remember is healing time. It's different for different parts of the body.
Your face has great blood supply it heals quickly. But your limbs, say your lower legs, can take up to three times longer to heal. It just requires patience.
Okay, this is a great place to shift focus from skin to hair. Hair loss is so prevalent. Over half of women report experiencing hair loss at some point, and it's often profoundly distressing. We know normal shedding is maybe 100 to 150 hairs a day that's just the hair cycle. Estrogen has a beautiful protective role here. It favors the anagen, or growth phase. It lets hair grow thick and long for maybe up to six years. When estrogen drops, that growth phase shortens.
Then we get the androgen problem. It's not that testosterone necessarily increases that's the key. It decreases relatively, because your protective estrogen drops. The normal amount of testosterone has less to balance it, and that testosterone converts into a much more potent hormone, DHT, through an enzyme called 5-alpha-reductase.
I remember you calling that “fatal to the follicle.”
It really is, because it causes miniaturization. The hair doesn't just fall out it grows back thinner, shorter, and finer with each cycle. Eventually it's just vellus hair fuzz. You see it at the temples or along the part line.
Exactly. And this is why diagnosis is so critical. You have to know why you're losing hair. Clinicians use something called trichoscopy for that.
Yes, it's a high-magnification view of the scalp. It tells us everything. If we see a mix of thick hairs next to miniaturized thin ones fat and skinny hairs that points to androgenetic alopecia, or female-pattern hair loss. That's a chronic condition. It requires continuous management.
But if we look and all the hairs are the same thickness, but there's just a lot of shedding, that's something else. That's typically telogen effluvium sudden shedding from a trigger like severe stress, surgery, or an underlying issue like anemia, low ferritin, or a thyroid problem. In that case, you have to treat the root cause, not just the hair. Topical products won't fix a deficiency.
The third type, the more serious one, would be frontal fibrosing alopecia, a scarring alopecia. The follicle dies and can't be revived, and the hairline recedes dramatically. In that case, the “soil” is bad, so to speak, so transplants aren't effective.
The big takeaway here sounds like urgency. If you think you're losing hair, see someone early as early as possible. Once a follicle dies, it's gone.
For treatments, clinicians often start with minoxidil, which can help prolong that growth phase. That can be topical or a low-dose oral pill.
Right. And the oral route can often be more effective for many people. It was originally a blood pressure medication, so there's a small risk of lightheadedness, which is why you suggest taking it at night.
Exactly. We use a very low dose, and taking it at night mitigates that risk. For many, the improvement in hair density makes it a worthwhile conversation with their provider.
And what about treatments that target the hormones directly for androgenetic alopecia?
Yes, there are 5-alpha-reductase inhibitors like finasteride, but we have to stress those are only for women past childbearing age due to risks of birth defects. Then there are antiandrogens like spironolactone that help block the receptor itself.
This brings us back to the systemic connection again. You mentioned thyroid research suggests low thyroid function may affect a significant number of women in menopause. It can be a huge driver for both hair loss and brittle nails. It's never just one thing. We always have to look at the full picture.
Speaking of a full picture, let's move to our third topic an area that's vital for health but so often hidden: genitourinary syndrome of menopause, or GSM. It's a medical reality. GSM is a set of chronic symptoms affecting the whole system down there vulva, vagina, urethra, bladder and it's driven entirely by estrogen deficiency.
So what is the lack of estrogen actually doing to those tissues? Estrogen is the maintenance worker for the vaginal ecosystem. It promotes glycogen, which the good bacteria lactobacilli feed on. They convert it to lactic acid, which keeps the vaginal pH acidic. That acidic environment is your defense against infection. When estrogen crashes, the pH becomes more alkaline, and that leads to more infections, recurrent UTIs, and yeast infections.
Physically, the vaginal wall thins. It loses its folds and elasticity. Blood flow decreases, which means poor lubrication and fragility.
And the symptoms are so common, yet so underdiagnosed. What should people be aware of?
Dyspareunia that's pain during sex or persistent irritation and burning. It also affects the urinary tract, so painful urination, waking up at night to urinate, urgency, frequency. It's all connected.
And it's treatable. What are the treatments?
Local hormones are often considered first line. They're highly effective. A very low dose of estradiol or estriol applied vaginally can restore that pH, rebuild the mucosal thickness, and really ease relations.
For someone who can't or doesn't want to use hormones, non-hormonal options like hyaluronic acid applied intravaginally can be a great humectant to bind water to the tissue. And of course, simple water-based lubricants during intimacy help a lot.
In our practice at Hormona Vida, we also sometimes utilize vaginal laser treatments. The fractional CO₂ laser uses microablative energy to stimulate new collagen and improve circulation. It can promote rejuvenation both internally and externally.
And finally, let's touch on the pelvic floor. Incontinence affects so many women somewhere between about 25% and 45%. The key is strengthening the pubococcygeus muscle; it's like a supportive hammock. Kegels are the classic advice, but they can be hard to do correctly and consistently.
That's where technology like the Emsella chair comes in. It uses high-intensity focused electromagnetic (HIFEM) technology to induce about 11,200 supramaximal contractions in a 28-minute session contractions you just can't achieve on your own. A series of treatments can significantly strengthen that hammock and reduce urgency and leakage.
It's just fascinating. Whether we're talking skin elasticity, hair density, or pelvic floor health, it all points back to needing comprehensive, systemic support. The body needs proactive attention from face to vagina, it's all intertwined.
BHRT, topicals, weight training, stress management, sleep these are all essential for managing midlife changes with confidence.
And as a final thought for you to explore: if you notice seemingly isolated issues like sudden hair loss or brittle nails, remember to check the underlying causes. Low thyroid function, for example, could be the primary driver. Don't just treat the symptom always connect the dots.
We strongly encourage you to use this information to have a really informed, detailed conversation with your own health care provider about your unique needs. And a crucial reminder: this deep dive is for educational purposes only and does not replace personalized medical advice. All decisions regarding products or treatments hormones, supplements, procedures must be made in consultation with a qualified clinician who knows your full medical history.
References
- Thornton MJ. Estrogens and aging skin. Review of how estrogen supports skin thickness, collagen, elasticity, hydration and sebaceous function, and how menopause-related estrogen decline accelerates visible skin aging. pmc.ncbi.nlm.nih.gov.
- Shah MG, Maibach HI. Estrogen and skin. An overview. Summarizes estrogen’s role in fibroblast activity, collagen and elastin synthesis, and its relevance to menopausal skin changes and hormone therapy. pubmed.ncbi.nlm.nih.gov.
- Brincat MP. Hormone replacement therapy and the skin. Classic work describing the rapid postmenopausal drop in skin collagen (including the “collagen cliff”) and how estrogen therapy can partially reverse these changes. pubmed.ncbi.nlm.nih.gov.
- Quan T, Fisher GJ. Role of matrix-degrading metalloproteinases in human skin aging and photoaging. Explains how UV-induced oxidative stress activates matrix metalloproteinases (MMPs) that degrade existing collagen, compounding age and hormone-related collagen loss. pubmed.ncbi.nlm.nih.gov.
- Fluhr JW, et al. Xerosis cutis dry skin in the elderly. Reviews the high prevalence of chronic dry skin (xerosis cutis) in older adults, mechanisms of barrier impairment, and links with pruritus and dermatitis. pubmed.ncbi.nlm.nih.gov.
- Cruz-Jentoft AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Defines age-related muscle loss, noting progressive decline in muscle mass and strength from midlife and supporting resistance training as a key intervention. pubmed.ncbi.nlm.nih.gov.
- Cario M, et al. Melasma and the role of female sex hormones. Describes how estrogen and progesterone influence melanocyte activity in melasma and other forms of hormonally driven hyperpigmentation. pubmed.ncbi.nlm.nih.gov.
- Brough KR, Torgerson RR. Hormonal therapy in female pattern hair loss. Reviews female pattern hair loss, the role of androgens and dihydrotestosterone (DHT), follicular miniaturization, and therapies including 5α-reductase inhibitors and spironolactone. pubmed.ncbi.nlm.nih.gov.
- Carmina E, et al. Female pattern hair loss and androgen excess. Explores the overlap between female pattern hair loss, androgen excess, and midlife hormonal shifts, emphasizing the need for thorough endocrine evaluation. pubmed.ncbi.nlm.nih.gov.
- American Academy of Dermatology. Hair shedding: What’s normal? Patient-oriented overview explaining that shedding around 50–100 hairs per day is typical, and outlining red flags for excessive hair loss. aad.org.
- Taguchi T. Brittle Nails and Hair Loss in Hypothyroidism. Case report highlighting hypothyroidism as a reversible cause of hair loss and brittle nails, underscoring the importance of thyroid evaluation in such presentations. pubmed.ncbi.nlm.nih.gov.
- The North American Menopause Society (NAMS). The 2020 genitourinary syndrome of menopause position statement. Defines GSM as a chronic condition caused by estrogen deficiency affecting vulva, vagina, urethra and bladder, and recommends low-dose vaginal estrogen as first-line therapy. pubmed.ncbi.nlm.nih.gov.
- Rossi R, et al. Non-hormonal management of genitourinary syndrome of menopause: focus on hyaluronic acid. Summarizes evidence that intravaginal hyaluronic acid preparations can improve dryness and dyspareunia in GSM, sometimes showing similar symptomatic relief to low-dose estrogen. pubmed.ncbi.nlm.nih.gov.
- Javaheri A, et al. Fractional CO2 laser for genitourinary syndrome of menopause. Clinical study of fractional CO2 laser showing improved vaginal symptoms, lubrication and tissue quality in women with GSM, likely via collagen remodeling and increased blood flow. pubmed.ncbi.nlm.nih.gov.
- Cacciari LP, Dumoulin C, et al. Pelvic floor muscle training versus no treatment for urinary incontinence in women. Cochrane systematic review showing pelvic floor muscle training significantly improves or cures stress and mixed urinary incontinence, supporting it as first-line therapy. rbf-bjpt.org.br.
- Tosun H, et al. Is the High-Intensity Focused Electromagnetic Energy an Effective Treatment for Urinary Incontinence in Women? Prospective study of HIFEM chair therapy (e.g., EMSELLA) showing significant improvement in stress and mixed urinary incontinence after sessions inducing thousands of supramaximal pelvic contractions. pubmed.ncbi.nlm.nih.gov.
- Chen P, Li B, Ou-Yang L. Role of estrogen receptors in health and disease. Detailed review of estrogen receptor alpha and beta distribution in tissues (including reproductive tract, bone and skin) and the rationale for selective estrogen receptor modulators (SERMs). frontiersin.org.
- Draelos ZD. Topical and oral estrogens for skin rejuvenation. Examines clinical data on systemic and topical estrogen improving dermal thickness, elasticity and collagen content in postmenopausal women. pubmed.ncbi.nlm.nih.gov.
